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1. Introduction 
A specific inhibitor of the calcium-activated neutral 
proteinase (CaANP) detected first in [ 1 ] was subse- 
quently purified from rabbit skeletal muscle [2] and 
bovine cardiac muscle [3]. When we have purified 
CaANP from rabbit skeletal muscle, no calcium-stim- 
ulated proteolytic activity on casein could be detected 
in the crude extract but after sepuation from the 
inhibitor by ion-exchange chromatography, this 
activity was easily measured. The presence of a similar 
proteinase inhibitor was also demonstrated in various 
other tissues (brain, lung, heart, liver) [4-6]. The 
simultaneous presence of CaANP [5-lo] in these 
tissues eems to indicate that proteolysis by this 
enzyme may be closely controlled. Ca2+ may play a 
role in the association between the enzyme and its 
specific inhibitor [3,5,11]. 
CaANP was made from the homogenate according 
to our standard procedure up to the Szoo step [ 121. 
Consequently, the enzyme still contained one 73 000 
M, and two 30 000 Mr polypeptide chains. Casein 
(Merck) was used as a substrate to quantitate proteol- 
ytic activity as in [ 121. 
This work examines the effects of Ca2+ on the 
mechanism of the enzyme-inhibitor interactions. 
The results obtained show that the association is
dependent on Ca2+ while chelating agents (EDTA or 
EGTA) induce a partial dissociation of the complex. 
The inhibitor does not bind to the enzyme through 
Ca2+ but to the enzyme-Ca2+ complex which repre- 
sents the ‘active form’. 
A separate portion of the homogenate was used 
for the preparation of the inhibitor by a modification 
of the method in [2]. After centrifugation (27 000 X g 
for 40 min) the supernatant was run on a column of 
DEAE-Sephacel(2.5 X 60 cm) equilibrated in 5 mM 
Tris-HCl buffer (pH 7.4) containing 0.1 mM EDTA, 
50 mM NaCl and 2 mM 2-mercaptoethanol. The 
inhibifor was then eluted from the column by a linear 
gradient of NaCl (So-500 mM) in the same buffer. 
The pooled inhibitor fractions were adjusted to 30% 
saturation ammonium sulfate solution by dialysis at 
4’C. The insoluble material was removed by centrifu- 
gation (30 000 X g for 20 min) and the supernatant 
applied to a column of octyl-Sepharose (2.5 X 20 cm) 
equilibrated with a buffer containing 5 mM Tris-HCI 
@H 7.40), 50 mM NaCl, 3 mM 2-mercaptoethanol. 
The inhibitor was eluted with the same buffer con- 
taining 10% saturated (NH4)2S04, the active fractions 
were pooled, dialysed overnight and then purified as 
before using organo-mercurial Sepharose and Ultrogel 
AC A44 [2]. 
2. Experimental procedure Inhibitor activity was determined by our standard 
assay [2]. 
2.1. Purification of GzANPand inhibitor 
Fresh rabbit (Fauve de Bourgogne) skeletal muscle 
was homogenized in 2.5 vol. 5 mM Tris-HCI buffer 
(PH 7.40) containing 4 mM EDTA, 50 mM NaCl and 
2 mM 2-mercaptoethanol as in [ 121 and used as the 
starting material for the preparation of CaANP and 
its inhibitor. 
2.2. Immobilization of inhibitor and ChANP 
The inhibitor-conjugated Sepharose was prepared 
as described in Pharmacia Fine Chemical AB. Pure 
inhibitor (10 mg) was mixed with 1.5 mg pre-swollen 
CNBr-activated Sepharose. The binding efficiency of 
the protein to the matrix (evaluated using protein 
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determination on inhibitory activity) was -75%. 
CaANP SZoo (-15 mg) was adsorbed to DEAE- 
Sephacel column (1.5 X 10 cm) using Tris-HCl 
buffer (PH 7.40) containing 180 mM NaCl, 0.1 mM 
EDTA and 2 mM 2-mercaptoethanol. 
The interaction of inhibitor, enzyme and activa- 
tion was tested by measuring the proteolytic activity 
eluted from the column [2,12]. 
2.3. Other methods 
Protein concentrations were determined by the 
modification [131 of the method in [ 141 using bovine 
serum albumin as standard. Analytical SDS gel elec- 
trophoresis was performed according to [ 121. Ca*+ 
concentrations were estimated using a Pye Unicam 
atomic absorption spectrometer. 
3. Results and discussion 
3 .l . Binding of the CaANP to the CNBr-activated 
Sepharose-inhibitor column 
The involvement ofCa*+ in the association between 
enzyme and inhibitor was evaluated by measuring the 
binding of the enzyme to the column in presence or 
absence of Ca*+. 
Fig.1 shows that the amount of CaANP bound is a 
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Fig.1. Effect of Ca2+, SrZ+ and Mg*+ on the association enzyme- 
inhibitorconjugated Sepharose. Aliquots of CaANP (250 r.d = 
10 units) were applied with each concentration of divalent 
ions between O-3 mM, on the inhibitor-conjugated Sepharose 
column (1.5 X 2 cm) equilibrated in 10 mM Tris-HCl 
(pH 7.40), 300 mM NaCl, 2 mM 2-mercaptoethanol. The 
column was eluted with a buffer containing (o-o) CaCl,; 
(e-e) SrCl, or (~----a) MgCl,. Aliquots (200 ~1) of each 
column fraction were assayed for protease activity. 
function of [Ca”]; 50% of the total bound was 
obtained with a 1.5 mM Ca*+ solution. Other ions like 
Mg*+ and Sr*+ used at the same concentrations had no 
effect on the association of enzyme and inhibitor 
even at 3 mM. 
The enzyme-Ca*+--inhibitor complex is dissociated 
by chelating agents like EDTA and EGTA. When 
EDTA and EGTA concentrations were increased from 
0.5-3 mM, the percent of free enzyme recovered was 
also increased (fig.2) reaching -50% of the activity 
loaded on to the column originally. 
Electrophoretic analysis (fig.3) of the eluate from 
the inhibitor-conjugated Sepharose column shows 
that only the 73 000 M, component is bound to the 
inhibitor in presence of calcium. 
3.2. Binding of the inhibitor to the immobilized 
DEAE-Sephacel CaANP 
During the preparation of inhibitor and enzyme 
[2], we have shown that these two molecules were 
both adsorbed by DEAE-Sephacel and eluted from 
the ion-exchange column at 0.1 and 0.35 M NaCl, 
respectively, when a linear gradient of ionic strength 
Fig.2. Effect of chelating agents on the dissociation of the 
enzyme-inhibitor complex. For each experiment, an aliquot 
of CaANP (250 ~1 N 10 units) was applied on the inhibitor- 
conjugated Sephruose column (1.5 X 2 cm) equilibrated in 
10 mM Tris-HCl (pH 7.40), 300 mM NaCl, 2 mM 2-mercap- 
toethanol and 3 mM CaCl,. After washing with the equili- 
bration buffer, the enzyme was eluted with 10 mM Tris-HCl 
(pH 7.40), 300 mM NaCl, 2 mM 2mercaptoethanol and 
EGTA at one concentration (between 0.5 -3 mM). Eluted 
column fractions were assayed and pooled for protease activ- 
ity. After each experiment, the inhibitor-conjugated Sepharose 
was regenerated using a buffer containing 10 mM Tris-HCl 
(pH 7.40), 300 mM NaCl, 2 mM 2-mercaptoethanol and 
3 mM EGTA. 
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Fig.3. SDS-polyacrylamide gel electrophoresis before and 
after binding to the inhibitor-Sepharose 4B column: (a) 
CaANP (S,,, ) without calcium; (b) CaANP (S,,,) with 3 mM 
calcium; (c) CaANP (S,,,) bound to the inhibitor-Sephsrose 
4B column and eluted; (d) purified inhibitor as used in the 
coupling reaction to the CNBr-activated Sepharose 4B; (e) 
standard proteins (M,): phosphorylase B, (98 000); bovine 
serum albumin (68 000); carbonic anhydrase (30 000); 
a-lactalbumm (14 000). 
was applied. Between those two values of ionic 
strength only the enzyme is bound to the matrix. 
Even with a high concentration of Ca2+ (3 mM) in 
the buffer, the inhibitor was stilI eluted indicating 
that there was no complex formation on this support. 
3.3. Calcium binding to the inhibitor 
Unlike CaANP, the inhibitor is stable in solutions 
containing calcium. To study calcium binding by the 
inhibitor, experiments using equilibrium dialysis were 
performed in microcells. At various protein (l-3 mg 
in 2 ml) and calcium (0.2-3 mM) levels, no binding 
was detected in our experimental system. 
4. Discussion 
Most cells, including muscle cells contain both the 
CaANP and its specific inhibitor [4,9]. The proteinase 
is activated in vitro by calcium. Inhibition did not 
result from competition for Ca*+ by the inhibitor 
[2,15]. The results obtained here agree with those in 
[3,5,1 l] showing a Ca*+-dependent regulation of 
CaANP. Therefore the inhibition mechanism can be 
explained by either of two hypotheses: 
(1) Ca*+ provide the link between the enzyme and its 
inhibitor; 
(2) Ca*’ bound by the enzyme induce a structural 
modification which promotes complex formation 
with the inhibitor. 
Our results accord with the second hypothesis, 
since: 
(i) The use of inhibitor-conjugated Sepharose has 
given direct proof that there is interaction 
between the enzyme and inhibitor in the presence 
of calcium ; 
(ii) Using equilibrium dialysis we have shown that 
the inhibitor does not bind calcium; 
(iii) The adsorption of the enzyme on DEAE-Sephacel 
(which neutralises negative charges on the mole- 
cule) suppresses the interaction of the inhibitor, 
probably because the calcium can no longer bind 
electrostatically to the enzyme. 
These conclusions are confirmed by the observa- 
tions [ 1 l] that one inhibitor molecule could inactivate 
and link 10 enzyme molecules, Such an observation 
would be very unlikely if Ca*+ provided the linkage. 
These experiments provide evidence for an indirect 
role of calcium in the association of CaANP with its 
inhibitor. 
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